Kontakte:Errol Zhou (Mesye.)
Tel: plis 86-551-65523315
Mobile/WhatsApp: plis 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Imèl:sales@homesunshinepharma.com
Ajoute:1002, Huanmao Bilding, No.105, Mengcheng Wout, Hefei Vil, 230061, Lachin
CAS Non: 179324-69-7
Fòmil Molekilè: C19H25BN4O4
Pwa molekilè: 384.237
EINECS NON: 605-854-3
MDL NON: MFCD05260688
Deskripsyon pwodwi:
Non pwodwi: Bortezomib CAS 179324-69-7
Sinonim:
3-metil-1 - ((S) -3-fenil-2- (pirazin-2-karboksamido) propanamido) butilboronik asid;
B - [(1R) -3-Methyl-1 - [[(2S) -1-oxo-3-phenyl-2 - [(2-pyrazinylcarbonyl) amino] propil] amino] butil] boronik Asid;
Chimik& Pwopriyete fizik:
Aparans: Blan Poud Off-White
Egzamen: ≥99.0%
Dansite: 1.214
Pwen fizyon: 122-124 ℃
PSA: 124.440
LogP: 2.45
Refractive Index: 1.564
Solitid: idrosolubl nan kloroform, dimetil sulfoksid, etanòl ak metanòl.
Estabilite: igroskopik ak imidite sansib
Kategori: amin, metabolit& Enpurte, Nukleotid, Baz& Reyaktif ki gen rapò,
Enfòmasyon sou sekirite:
HS Kòd: 2934999090
Fraz Sekirite S26-S36 / 37/39
RIDADR: 3261
RTECS NON: ED7771666
Depo:Igroskopik, -20 ° C frizè, anba atmosfè inaktif.
Aplikasyon:1. [(1R) -3-Methyl-1 - [[(2S) -1-oxo-3-phenyl-2 - [(pyrazinylcarbonyl) amino] propil] amino] butil] boronik Asid se premye inibitè proteasom ki dwe apwouve pa US FDA pou myelom miltip, yon kansè nan san. Yon inibitè revèsib nan 26S proteasome-yon barik ki gen fòm patikil multiprotein yo te jwenn nan nwayo a ak cytosol nan tout selil ekaryotik. Sib chemen ubiquitin-proteasome.
2. Bortezomib (PS-341) se yon inibitè ki pisan 20S proteasome ak yon Ki nan 0.6 nM.
Bortezomib CAS fabrikasyon faktori nou an 179324-69-7, teknoloji ki gen matirite, pwodiksyon ki estab, asirans kalite.
Estati Envantè: Nan Stock.
Nou ka bay CAS 179324-69-7 sètifika analiz (COA), N - [(1R) -1- (Dihydroxyboryl) -3-methylbutyl] -Nα- (pyrazin-2-ylcarbonyl) -L-phenylalaninamide MOA, Bortezomib ROS, MSDS ak lòt sipò pou ou!
Si ou enterese nan pwodwi nou yo oswa ou gen nenpòt kesyon, tanpri ou lib pou kontakte nou!
Pwodwi ki anba patant yo ofri pou R& D objektif sèlman. Sepandan, responsablite final la manti sèlman ak achtè a.
Baj popilè: bortezomib cas 179324-69-7, manifaktirè, founisè, faktori, achte, nan stock